 | • レポートコード：MRC2302E0086 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、241ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に1,165.48百万ドルであった世界のロングリードシーケンシング市場規模が、2022年に1,460.69百万ドルに達し、2027年には年平均成長率25.50%で4,555.27百万ドルまで成長すると予測しています。当調査レポートでは、ロングリードシーケンシングの世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、技術別（ナノポアシーケンシング、1分子リアルタイムシーケンシング）、製品別（消耗品、機器、サービス）、ワークフロー別（データ分析、プレシーケンシング、シーケンシング）、用途別（癌、構造変化の識別＆詳細マッピング、偽遺伝子識別、生殖ゲノミクス、その他）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、10x Genomics, Inc.、BaseClear B.V.、Bionano Genomics, Inc.、Dovetail Genomics, LLC、F. Hoffmann-La Roche Ltd、Future Genomics Technologies B.V.、Honeywell International Inc.、Illumina, Inc.、Intel Corporation、Keygene N.V.、Longas Technologies、MicrobesNG、MyJoVE Corporation、Oxford Nanopore Technologies Limitedなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のロングリードシーケンシング市場規模：技術別 - ナノポアシーケンシングの市場規模 - 1分子リアルタイムシーケンシングの市場規模 ・世界のロングリードシーケンシング市場規模：製品別 - 消耗品の市場規模 - 機器の市場規模 - サービスの市場規模 ・世界のロングリードシーケンシング市場規模：ワークフロー別 - データ分析の市場規模 - プレシーケンシングの市場規模 - シーケンシングの市場規模 ・世界のロングリードシーケンシング市場規模：用途別 - 癌における市場規模 - 構造変化の識別＆詳細マッピングにおける市場規模 - 偽遺伝子識別における市場規模 - 生殖ゲノミクスにおける市場規模 - その他用途における市場規模 ・世界のロングリードシーケンシング市場規模：地域別 - 南北アメリカのロングリードシーケンシング市場規模 アメリカのロングリードシーケンシング市場規模 カナダのロングリードシーケンシング市場規模 ブラジルのロングリードシーケンシング市場規模 … - アジア太平洋のロングリードシーケンシング市場規模 日本のロングリードシーケンシング市場規模 中国のロングリードシーケンシング市場規模 インドのロングリードシーケンシング市場規模 韓国のロングリードシーケンシング市場規模 台湾のロングリードシーケンシング市場規模 … - ヨーロッパ/中東/アフリカのロングリードシーケンシング市場規模 イギリスのロングリードシーケンシング市場規模 ドイツのロングリードシーケンシング市場規模 フランスのロングリードシーケンシング市場規模 ロシアのロングリードシーケンシング市場規模 … - その他地域のロングリードシーケンシング市場規模 ・競争状況 ・企業情報 |
The Global Long Read Sequencing Market size was estimated at USD 1,165.48 million in 2021 and expected to reach USD 1,460.69 million in 2022, and is projected to grow at a CAGR 25.50% to reach USD 4,555.27 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Long Read Sequencing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Nanopore Sequencing and Single-Molecule Real-Time Sequencing.
Based on Product, the market was studied across Consumables, Instruments, and Services.
Based on Workflow, the market was studied across Data Analysis, Pre-sequencing, and Sequencing.
Based on Application, the market was studied across Cancer, Identification & Fine Mapping Of Structural Variation, Pseudogene Discrimination, Reproductive Genomics, Resolving Allele Phasing, Tandem Repeat Sequencing, and Viral & Microbial Sequencing.
Based on End-user, the market was studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Long Read Sequencing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Long Read Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Long Read Sequencing Market, including 10x Genomics, Inc., BaseClear B.V., Bionano Genomics, Inc., Dovetail Genomics, LLC, F. Hoffmann-La Roche Ltd, Future Genomics Technologies B.V., Honeywell International Inc., Illumina, Inc., Intel Corporation, Keygene N.V., Longas Technologies, MicrobesNG, MyJoVE Corporation, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Quantapore, Inc., Sage Science, Inc., Takara Bio USA Holdings, Inc., TATAA Biocenter, and Thermo Fisher Scientific Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Long Read Sequencing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Long Read Sequencing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Long Read Sequencing Market?
4. What is the competitive strategic window for opportunities in the Global Long Read Sequencing Market?
5. What are the technology trends and regulatory frameworks in the Global Long Read Sequencing Market?
6. What is the market share of the leading vendors in the Global Long Read Sequencing Market?
7. What modes and strategic moves are considered suitable for entering the Global Long Read Sequencing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of genetic disorder globally
5.1.1.2. Surge in awareness coupled with demand for personalized medicine
5.1.1.3. Increasing application in clinical sequencing and analysis
5.1.2. Restraints
5.1.2.1. Need for higher volumes of input sample for analysis and throughput compared to short read sequencing
5.1.3. Opportunities
5.1.3.1. Rising advancement in third-generation long read sequencing techniques
5.1.3.2. Extensive spending on research and development in sequencing
5.1.4. Challenges
5.1.4.1. Relatively high cost and technical challenges in the process of long read sequencing
5.2. Cumulative Impact of COVID-19
6. Long Read Sequencing Market, by Technology
6.1. Introduction
6.2. Nanopore Sequencing
6.3. Single-Molecule Real-Time Sequencing
7. Long Read Sequencing Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Instruments
7.4. Services
8. Long Read Sequencing Market, by Workflow
8.1. Introduction
8.2. Data Analysis
8.3. Pre-sequencing
8.4. Sequencing
9. Long Read Sequencing Market, by Application
9.1. Introduction
9.2. Cancer
9.3. Identification & Fine Mapping Of Structural Variation
9.4. Pseudogene Discrimination
9.5. Reproductive Genomics
9.6. Resolving Allele Phasing
9.7. Tandem Repeat Sequencing
9.8. Viral & Microbial Sequencing
10. Long Read Sequencing Market, by End-user
10.1. Introduction
10.2. Academic Research
10.3. Clinical Research
10.4. Hospitals & Clinics
10.5. Pharma & Biotech Entities
11. Americas Long Read Sequencing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Long Read Sequencing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Long Read Sequencing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. 10x Genomics, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. BaseClear B.V.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bionano Genomics, Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Dovetail Genomics, LLC
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. F. Hoffmann-La Roche Ltd
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Future Genomics Technologies B.V.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Honeywell International Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Illumina, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Intel Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Keygene N.V.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Longas Technologies
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. MicrobesNG
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. MyJoVE Corporation
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Oxford Nanopore Technologies Limited
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. PerkinElmer Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Quantapore, Inc.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Sage Science, Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Takara Bio USA Holdings, Inc.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. TATAA Biocenter
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Thermo Fisher Scientific Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
